top of page
Introducing Dr.Noon
Chorleywood Eye Centre is excited to announce that it has become one of the first clinics in the UK to offer the world’s first AI-powered cardiovascular screening technology, which uses retinal imaging to deliver accurate cardiovascular disease (CVD) risk results in just 3 minutes.
​
In partnership with Heart Eye, the innovative technology, Dr.Noon CVD, is now available to patients at Chorleywood Eye Centre , bringing cutting-edge, non-invasive diagnostics to the forefront of cardiovascular health.
What is Dr.Noon CVD?
Chorleywood Eye Centre is excited to announce that it has become one of the first clinics in the UK to offer the world’s first AI-powered cardiovascular screening technology, which uses retinal imaging to deliver accurate cardiovascular disease (CVD) risk results in just 3 minutes.
​
In partnership with Heart Eye, the innovative technology, Dr.Noon CVD, is now available to patients at Chorleywood Eye Centre , bringing cutting-edge, non-invasive diagnostics to the forefront of cardiovascular health.
How It Works
Fast, accurate, and non-invasive cardiovascular risk assessment in just 3 minutes
Dr.Noon CVD analyses retinal images with advanced AI algorithms, providing clinicians with accurate cardiovascular risk assessments that are equivalent to heart CT scans but without the associated drawbacks. Unlike traditional diagnostic methods such as heart CT scans or carotid ultrasounds, which involve radiation exposure, high costs, and longer wait times, Dr.Noon CVD offers a fast, affordable and safe alternative with results available in just three minutes.​ It's non-invasive and radiation-free: patients can avoid blood tests and radiation exposure.
bottom of page